Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Eucomed asks: is device reuse really worth it?:

This article was originally published in Clinica

Executive Summary

The costs of validating whether a medical device can safely be reprocessed and reused could be anything between $7,000 and $50,000, according to the European medical device industry association, EUCOMED. In a recent position paper, it argues that reprocessing creates many additional, often unforeseen, costs. These are normally related to stocking, storing, distribution and recording. But they may also arise because of patients needing treatment for infections resulting from reused devices, and even in compensation for medical negligence claims.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT067118

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel